Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma
Yuyao Li,Yue Li,Jinghao Zhang,Longshan Ji,Man Li,Xuehua Sun,Hai Feng,Zhuo Yu,Yueqiu Gao
DOI: https://doi.org/10.2147/JHC.S346047
2022-02-10
Journal of Hepatocellular Carcinoma
Abstract:Yuyao Li, 1, &ast Yue Li, 1, &ast Jinghao Zhang, 2 Longshan Ji, 3 Man Li, 3 Xuehua Sun, 2 Hai Feng, 1 Zhuo Yu, 2 Yueqiu Gao 1, 2 1 Institute of Infectious Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China; 2 Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China; 3 Laboratory of Cellular Immunity, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhuo Yu; Yueqiu Gao, Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Pudong New District, Shanghai, 201203, People's Republic of China, Tel +86 21 2025 6507, Fax +86 21 20256699, Email ; Hepatocellular carcinoma (HCC) is one of the leading lethal tumors worldwide, and the treatment remains a great medical challenge. Surgery and chemotherapy are current standard curative methods for patients with HCC, but the prognosis is still dismal. Based on unique medical theories and rich practical experience, traditional Chinese medicine (TCM) has been broadly employed to effectively treat HCC for a long history. Recently, systematic clinical trials have been well designed to study the efficacy of TCMs in the treatment of HCC, and the underlying antitumor mechanisms were also deeply explored. Here, we reviewed the published clinical evaluation of some commonly used TCMs in the treatment of HCC, and the related anti-HCC mechanisms through in vitro and in vivo study, promoting the modernization of TCM study in oncology for achieving a substantial reduction of HCC burden in the future. Keywords: traditional Chinese medicine, hepatocellular carcinoma, antitumor mechanism, tumor therapy, active ingredient Hepatocellular carcinoma (HCC) ranks the sixth most common malignant neoplasm and the third cancer-caused death worldwide. 1 Epidemiology demonstrated that the incidence of HCC is still rapidly increasing globally, especially in Europe and the United States. 2 Although multiple noninvasive imaging-based surveillance avenues have been developed for the diagnosis of HCC, the beneficiary effect is limited by the uncertain presentation of HCC pathological changes in early stage. 3 Surgical resection and liver transplantation are the current standard curative avenues for patients with regional HCC in early stage. However, the medical difficulties including high frequency of postoperative recurrence and the scarcity of donor liver resource seriously weaken the therapeutic efficacy on patients. 4 Multi-kinase inhibitors including sorafenib and regorafenib have been approved to treat the unresectable or advanced HCC, but the improvement of patient survival quality is restricted due to drug resistance caused by the long-term administration. 5 Therefore, other effective alternative therapeutic strategies with lower cost and fewer side effects are urgently required for the treatment of HCC. Traditional Chinese medicine (TCM) has a long history for the treatment of cancer including HCC. The plethora of accumulated experience in the long-term therapeutic practice promotes the construction of unique medical theories of TCM. The holism of human body and the concept of treatment according to syndrome differentiation are the central foundation of these theories and become the vital principle of TCM in the diagnosis and treatment of cancer. In these theories, liver is the soul of the human body, functioning to store the blood, control the sinews, and maintain a smooth and uninterrupted flow of qi . 6 HCC is the consequence of systemic disease with causative cumulative toxicity, vital qi deficiency and qi flow stasis, leading to the disequilibrium of yin and yang . Therefore, the purpose of TCM treatment is to restore the balance of yin and yang in the body and keep the smooth flow of qi . The strategy of TCM in the treatment of HCC is to exert multiple methods according to different syndromes while treating the patients as a whole at the same time. Treatment methods, including nourishing yin , heat-clearing and detoxifying, invigorating blood and removing stasis, softening and resolving hard mass, and soothing liver qi stagnation, are correspondingly used upon these TCM theories to effectively improve the overall survival of patients with HCC. 7 Formula (Fufang) that int -Abstract Truncated-
oncology